Antisynthetase Syndrome Clinical Trials in Beijing, Beijing Municipality

A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome